Advanced search
Publication Cover
Leukemia & Lymphoma Volume 39, 2000 - Issue 5-6
Submit an article Journal homepage
56
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Mitoxantrone, Etoposide, Carboplatinum and Ara-C Combination Therapy (Meca) in Refractory and Relapsed Acute Leukemia

Chkistelle Ferrá Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, SpainCorrespondence[email protected]
,
Jcan J. Berlanga Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, SpainView further author information
,
David Gallardo Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
,
Idoia AncIan Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
,
David MarIan Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
,
Juan R Gonzaalez Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
,
Juan Peris Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
,
Juan Muñoz Department of Hematolagy, Hospital Principes de España, Barcelona, Spain
,
Josæ Sarraa Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
&
Alberto Grañena Department of Clinical Hemalologyy, Hospital Duran i Reynals, Institut Catala d'Oncologia, Barcelona, Spain
 show all
Pages 583-590 | Accepted 30 May 2000, Published online: 05 Aug 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fusako Sugita, Kazuhiro Maki, Yuka Nakamura, Ko Sasaki & Kinuko Mitani. (2014) Overexpression of MIR9 indicates poor prognosis in acute lymphoblastic leukemia. Leukemia & Lymphoma 55:1, pages 78-86.
Read now

Articles from other publishers (9)

Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz & Pau Montesinos. (2018) Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review. Annals of Hematology 97:7, pages 1115-1153.
Crossref
Kamal K.S. Abbi, Witold Rybka, W. Christopher Ehmann & David F. Claxton. (2015) Phase I/II Study of Clofarabine, Etoposide, and Mitoxantrone in Patients With Refractory or Relapsed Acute Leukemia. Clinical Lymphoma Myeloma and Leukemia 15:1, pages 41-46.
Crossref
Ki-Seong Eom, Woo-Sung Min, Hee-Je Kim, Byung-Sik Cho, Su-Mi Choi, Dong-Gun Lee, Seok Lee, Chang-Ki Min, Yoo-Jin Kim, Seok-Goo Cho, Jong-Wook Lee & Chun-Choo Kim. (2010) FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia. Medical Oncology 28:S1, pages 462-470.
Crossref
Tadeusz Robak & Agnieszka Wierzbowska. (2009) Current and emerging therapies for acute myeloid leukemia. Clinical Therapeutics 31, pages 2349-2370.
Crossref
Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta, Ewa Wawrzyniak, Barbara Cebula, Jerzy Hołowiecki, Sławomira Kyrcz-Krzemień, Sebastian Grosicki, Sebastian Giebel, Aleksander B. Skotnicki, Beata Piątkowska-Jakubas, Kazimierz Kuliczkowski, Marek Kiełbiński, Krystyna Zawilska, Janusz Kłoczko & Agata Wrzesień-Kuś. (2007) Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukem. European Journal of Haematology 80:2, pages 115-126.
Crossref
A. Wrzesień-Kuś, T. Robak, A. Wierzbowska, E. Lech-Marańda, A. Pluta, E. Wawrzyniak, A. Krawczyńska, K. Kuliczkowski, G. Mazur, M. Kiebiński, A. Dmoszyńska, M. Wach, A. Hellmann, W. Baran, J. Hołowiecki, S. Kyrcz-Krzemień & S. Grosicki. (2005) A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group. Annals of Hematology 84:9, pages 557-564.
Crossref
A. Wrzesień-Kuś, T. Robak, E. Lech-Marańda, A. Wierzbowska, A. Dmoszyńska, M. Kowal, J. Hołowiecki, S. Kyrcz-Krzemień, S. Grosicki, S. Maj, A. Hellmann, A. Skotnicki, W. Je˛drzejczak & K. Kuliczkowski. (2003) A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG). European Journal of Haematology 71:3, pages 155-162.
Crossref
D. Pastore, G. Specchia, P. Carluccio, A. Liso, A. Mestice, R. Rizzi, G. Greco, C. Buquicchio & V. Liso. (2003) FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Annals of Hematology 82:4, pages 231-235.
Crossref
. (2001) Current Awareness. Hematological Oncology 19:3, pages 121-128.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.